EIO Biomedical Preventing surgical adhesions safely

eu-logo.jpg

This project has received funding  from the European Union's Horizon 2020 research and innovation programme under grant agreement no 827874

 

EIO Biomedical’s solution –

an Innovative coagulation factors concentrate [Extrinsic system concentrate (ESC)]

תמונה1.png
  • Our solution is a spray containing critical blood clotting proteins

  • Can be used in both laparoscopic and open surgeries

  • These proteins leads to targeted clotting at the wound site, and change the way the Fibrin network is formed – cross linking Fibrin into a barrier to cells and adhesion formation

PATENT APPLICATIONS IN MAJOR COUNTRIES

  • Composition

  • Method of generating the extract

  • Method of treating adhesions

 

CONTACT US

Wadi El Haj 13 P.O. Box 1252, 
Nazareth  17111 Israel